Skip to search formSkip to main contentSkip to account menu

abacavir sulfate

A sulfate salt form of abacavir, a nucleoside reverse transcriptase inhibitor analog of guanosine. This agent decreases HIV viral loads, retards or… 
National Institutes of Health

Related topics

Related topics

14 relations

Narrower (4)

1592U89EpzicomTriumeqZiagen
Acquired Immunodeficiency SyndromeDrug AllergyHIV InfectionsNucleoside Analogs

Broader (1)

abacavir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Stability behaviour of antiretroviral drugs and their combinations. 9: Identification of incompatible excipients
2016
2016
Forced degradation study of abacavir sulfate under the frame of genotoxic impurity
Genotoxic impurities in drug substances or drug products are growing concern to ensure public health. Genotoxic impurities… 
2014
2014
Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan†
Abacavir is a nucleoside reverse transcriptase inhibitor indicated for human immunodeficiency virus (HIV) infection. In Japan… 
2014
2014
Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan†
To obtain safety and effectiveness data on a combined anti‐HIV drug, Epzicom (abacavir 600 mg/lamivudine 300 mg), a post… 
2009
2009
Spillover adherence effects of fixed-dose combination HIV therapy
The impact of fixed-dose combination (FDC) products on adherence to other, non-fixed regimen components has not been examined. We… 
2007
2007
Development and validation of a reverse-phase liquid chromatographic method for assay and related substances of abacavir sulfate.
A simple isocratic liquid chromatographic method was developed for the determination of abacavir from its related substances and… 
2006
2006
Bioequivalence of abacavir generic and innovator formulations under fasting and fed conditions.
OBJECTIVE Abacavir sulfate is a synthetic carbocyclic nucleoside analogue indicated for the treatment of HIV-1 infection in… 
2004
2004
Membrane permeation characteristics of abacavir in human erythrocytes and human T-lymphoblastoid CD4+ CEM cells: comparison with (-)-carbovir.
Review
2000
Review
2000
Section VII. Trends and perspectives
1999
1999
Abacavir sulfate (Ziagen).
  • P. Simmons
  • Research initiative, treatment action : RITA
  • 1999
  • Corpus ID: 23161390
Abacavir sulfate (Ziagen) received accelerated approval for treatment of HIV infection from the Food and Drug Administration… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)